Description

I'm a seasoned finance executive with over 15 years of experience driving financial strategy, scaling operations, and optimizing processes across tech, biotech, medtech and AI industries, ensuring businesses are set up for long-term success.

I specialize in financial planning, investor communication, audits, and fostering a culture of smart financial practices. My track record includes shortening audit timelines, streamlining reporting, and scaling operations from startups to large businesses. I enhanced cost efficiency and financial communication and honed my expertise in finance consulting and auditing at top firms like Grant Thornton.

I thrive in innovative environments, delivering both strategic impact and operational excellence.

Industry field of expertise

Languages

French
Native or bilingual
English
Fluent

Workplace preferences

Can work on-site

Paris (up to 50km)

MKy Finance
Managing Partner
January 2025 - Today (1 year and 5 months)
Mission: providing tailored financial leadership to startups and mid-sized companies, focusing on strategic planning and operational efficiency. Streamlining processes, and fostering a culture of smart financial practices. Ensuring companies are complying and optimized in accounting, taxes.
Owkin
SVP Finance
June 2018 - October 2024 (6 years and 4 months)
Scope: Responsible of finance strategy and corporate, Investors financial communication, Due Diligence, Finance Planning and Analysis, accounting and taxes, and Purchase.
Main achievements: Build and scale the team, operations, processes and tools (ERP, travel, purchase tools) Shorten audit timelines and reporting close dates Implement and spread a finance and smart purchase culture
Environment: Techbio Al for precision medicine, Support scale: valuation x8, revenues x40, FTE x20, finance team of 18 people, 3 fundraises totaling +250m, from SME to Large
Mauna Kea Technologies
Finance Director
September 2013 - May 2018 (4 years and 8 months)
Scope: Responsible for all financial communication, financial audits, public annual general assembly, PR agency relationship, AMF relationship
Main achievements: Costs monitoring and reductions, rolling cash forecast and Working capital optimization - Gained 8 months of runway Orchestrate the launch of the Reference Document accross the company Set up Free shares plan as BSPCE not eligible Organized public Annual General Assembly meeting with tight quorum
Environment: Medtech, Listed company support: Regulated financial communication - Cash difficulties